Not finding it? Sign in to also search OpenAlex live.
-
Decoding myofibroblast origins in human kidney fibrosis2020 Edinburgh Research Explorer (University of Edinburgh) dataset Medicine Chronic Kidney Disease and Diabetes Open access
Christoph Kuppe, Mahmoud M. Ibrahim, Jennifer Kranz, Xiaoting Zhang, Susanne Maria Ziegler, Jitske Jansen, +23 more
2citations -
Decoding myofibroblast origins in human kidney fibrosis2020 Zenodo (CERN European Organization for Nuclear Research) dataset Medicine Chronic Kidney Disease and Diabetes Open access
Christoph Kuppe, Mahmoud M. Ibrahim, Jennifer Kranz, Xiaoting Zhang, Susanne Maria Ziegler, Jitske Jansen, +23 more
0citations -
Immature Neutrophil Phenotype and Enhanced Myeloperoxidase in Male Patients With Chronic Kidney Disease and Cardiovascular Comorbidity2026 Acta Physiologica article Immunology and Microbiology Neutrophil, Myeloperoxidase and Oxidative Mechanisms Open access
Sonja Vondenhoff, Alessandra Antwerpen, Carolina Victória Cruz Junho, Sina Hourtz, Jinmi Zou, Berkan Kurt, +15 more
0citations -
CRISPR-Induced Knockout of Ubiquitin Ligase Cullin 3 in Human Proximal Tubule Cells2021 Journal of the American Society of Nephrology conference-abstract Biochemistry, Genetics and Molecular Biology CRISPR and Genetic Engineering
Turgay Saritas, Lu Chen, Susanne Maria Ziegler, Nazanin Kabgani, Christoph Kuppe, Jürgen Floege, +2 more
0citations -
Development of a Synthetic 3D Platform for Compartmentalized Kidney In Vitro Disease Modeling2025 Advanced Healthcare Materials article Engineering 3D Printing in Biomedical Research Open access
Ninon Möhl, Daphne Bouwens, Johanna Abele, A Heus Hans, Tanja Topic, Daniel Günther, +3 more
3citations -
Tviblindi algorithm identifies branching developmental trajectories of human B cell development2024 bioRxiv (Cold Spring Harbor Laboratory) preprint Immunology and Microbiology T-cell and B-cell Immunology Open access
Marina Bakardjieva, Jan Stuchlý, Ondřej Pelák, Marjolein W. J. Wentink, Hana Glier, David Novák, +6 more
1citations -
Primary and Safety Outcomes of a Phase 3 Open-Label, Single-Arm, 12-Week Study of Treatment with PI3Kδ Inhibitor Leniolisib in Pediatric Patients Aged 4–11 Years with Activated PI3Kδ Syndrome (APDS)2025 Journal of Human Immunity article Immunology and Microbiology Immunodeficiency and Autoimmune Disorders Open access
V. Koneti Rao, Manish J. Butte, Bénédicte Neven, Michaëla Semeraro, Yaël Gernez, Shanmuganathan Chandrakasan, +9 more
0citations -
Leniolisib, a Selective Phosphoinositide 3-Kinase Delta (PI3Kδ) Inhibitor, in Japanese Patients Aged 12 and Over with Activated PI3Kδ Syndrome (APDS): Data from a 12-Week, Open-Label, Single-Arm Study2026 Journal of Human Immunity article Immunology and Microbiology Immunodeficiency and Autoimmune Disorders Open access
Satoshi Okada, Hirokazu Kanegane, Ewen Munro, Jason Bradt, Anurag Relan
0citations
11 results